Primaquine Phosphate: Clinical Trials

7 trials of Primaquine Phosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 3 Phase 2, 2 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Not yet recruiting 1
Phase 32Completed 1, Not yet recruiting 1
Phase 42Completed 1, Unknown 1
Phase 11Completed 1

Follow Primaquine Phosphate: new trials by email Literature Review of Primaquine Phosphate trials Research Report on Primaquine Phosphate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postpartum 8-aminoquinoline Breast Milk Study
Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers
Phase 2 / Phase 3Not yet recruitingCurtin University602026-04-012026-03-18
Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali
Artesunate-amodiaquine combination, Primaquine Phosphate, Artemether-lumefantrine - Malaria,Falciparum
Phase 2CompletedLondon School of Hygiene and Tropical Medicine1002022-10-172024-10-01
Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali
Artemether-lumefantrine, Primaquine Phosphate, Sulphadoxine-pyrimethamine with amodiaquine - Malaria,Falciparum
Phase 2CompletedLondon School of Hygiene and Tropical Medicine802021-10-122022-01-18
Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen
RPQ, SPQ, Primaquine Phosphate - Malaria, Glucose 6 Phosphate Dehydrogenase Deficiency
Phase 1CompletedUniversity of Mississippi, Oxford362018-08-172019-05-14
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
Standard RDT and HS-RDT, Artemether-lumefantrine, Primaquine Phosphate - Plasmodium Falciparum Malaria
Phase 4CompletedUniversity of California, San Francisco399682017-11-282021-02-23
Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda
Primaquine - Falciparum Malaria
Phase 3CompletedLondon School of Hygiene and Tropical Medicine4682011-12-012013-06-12
Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
Primaquine - Plasmodium Vivax
Phase 4UnknownPapua New Guinea Institute of Medical Research1502010-06-012015-10-14

Conditions studied

Malaria, Falciparum (4)  ·  Malaria (2)  ·  Malaria, Vivax (2)  ·  Breast Feeding (1)  ·  Glucosephosphate Dehydrogenase Deficiency (1)  ·  Hemolysis (1)

Sponsors

London School of Hygiene and Tropical Medicine (3)  ·  Curtin University (1)  ·  Papua New Guinea Institute of Medical Research (1)  ·  University of California, San Francisco (1)  ·  University of Mississippi, Oxford (1)

Countries

Mali (2)  ·  Papua New Guinea (2)  ·  Laos (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Alassane Dicko (2)  ·  Adam Bennett, MA, PhD (1)  ·  Alice C Eziefula, MBBS MCRP MRCPath (1)  ·  Brioni Moore, PhD (1)  ·  Inoni Betuela, MD, PhD (1)  ·  Ivo Mueller, PhD (1)  ·  J Kevin Baird, PhD (1)  ·  Larry Walker, Phd (1)  ·  Timothy ME Davis, FRAC, PhD (1)

Results publications

PMID 24239324, PMID 27197604, PMID 32118199, PMID 37269941, PMID 38705163, PMID 39701119